loadpatents
name:-0.046772956848145
name:-0.030205011367798
name:-0.0024960041046143
KAUFMANN; Jorg Patent Filings

KAUFMANN; Jorg

Patent Applications and Registrations

Patent applications and USPTO patent grants for KAUFMANN; Jorg.The latest application filed is for "recombinant nucleic acid construct".

Company Profile
0.36.45
  • KAUFMANN; Jorg - Berlin DE
  • Kaufmann; Jorg - Chemnitz DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Recombinant Nucleic Acid Construct
App 20210261980 - GIESE; Klaus ;   et al.
2021-08-26
Method for Producing Security Elements in an Image Which are not Visible to the Human Eye and Cannot be Copied, and Printed Image
App 20210245542 - Kaufmann; Jorg ;   et al.
2021-08-12
Interfering Rna Molecules
App 20210062198 - GIESE; Klaus ;   et al.
2021-03-04
Interfering RNA molecules
Grant 10,774,332 - Giese , et al. Sept
2020-09-15
Interfering Rna Molecules
App 20190390201 - GIESE; Klaus ;   et al.
2019-12-26
Interfering RNA molecules
Grant 10,329,568 - Giese , et al.
2019-06-25
Interfering RNA molecules
Grant 10,323,246 - Giese , et al.
2019-06-18
Interfering RNA molecules
Grant 10,266,829 - Giese , et al.
2019-04-23
Means For Lung Specific Delivery
App 20190038557 - KEIL; Oliver ;   et al.
2019-02-07
Interfering Rna Molecules
App 20190024089 - GIESE; Klaus ;   et al.
2019-01-24
Interfering Rna Molecules
App 20180291381 - Giese; Klaus ;   et al.
2018-10-11
Interfering Rna Molecules
App 20180223286 - GIESE; Klaus ;   et al.
2018-08-09
Lipoplex Formulations For Specific Delivery To Vascular Endothelium
App 20170296469 - KAUFMANN; JORG ;   et al.
2017-10-19
Interfering RNA molecules
Grant 9,790,505 - Giese , et al. October 17, 2
2017-10-17
Interfering RNA molecules
Grant 9,790,501 - Giese , et al. October 17, 2
2017-10-17
Interfering RNA molecules
Grant 9,783,802 - Giese , et al. October 10, 2
2017-10-10
Interfering RNA molecules
Grant 9,758,784 - Giese , et al. September 12, 2
2017-09-12
Interfering Rna Molecules
App 20170247691 - GIESE; Klaus ;   et al.
2017-08-31
Interfering Rna Molecules
App 20170247697 - GIESE; Klaus ;   et al.
2017-08-31
Interfering Rna Molecules
App 20170247707 - GIESE; Klaus ;   et al.
2017-08-31
Interfering Rna Molecules
App 20170247698 - GIESE; Klaus ;   et al.
2017-08-31
Interfering RNA molecules
Grant 9,695,423 - Giese , et al. July 4, 2
2017-07-04
Lipids, Lipid Complexes And Use Thereof
App 20170036990 - KEIL; OLIVER ;   et al.
2017-02-09
Means For Lung Specific Delivery
App 20160303047 - KEIL; OLIVER ;   et al.
2016-10-20
Means for inhibiting the expression of ANG2
Grant 9,458,461 - Santel , et al. October 4, 2
2016-10-04
Coated lipid complexes and their use
Grant 9,387,262 - Keil , et al. July 12, 2
2016-07-12
Interfering Rna Molecules
App 20160130587 - Giese; Klaus ;   et al.
2016-05-12
Interfering RNA molecules
Grant 9,222,092 - Giese , et al. December 29, 2
2015-12-29
Lipids, Lipid Complexes And Use Thereof
App 20150359906 - KEIL; OLIVER ;   et al.
2015-12-17
Further Use Of Protein Kinase N Beta
App 20150337382 - KLIPPEL-GIESE; ANKE ;   et al.
2015-11-26
Lipids, lipid complexes and use thereof
Grant 9,125,820 - Keil , et al. September 8, 2
2015-09-08
Further use of protein kinase N beta
Grant 9,078,855 - Klippel-Giese , et al. July 14, 2
2015-07-14
Interfering Rna Molecules
App 20150105545 - GIESE; KLAUS ;   et al.
2015-04-16
Coated Lipid Complexes And Their Use
App 20150031752 - KEIL; OLIVER ;   et al.
2015-01-29
Interfering RNA molecules
Grant 8,933,215 - Giese , et al. January 13, 2
2015-01-13
Lipids, Lipid Complexes And Use Thereof
App 20140329885 - KEIL; OLIVER ;   et al.
2014-11-06
Means For Inhibiting The Expression Of Ang2
App 20140328903 - SANTEL; ANSGAR ;   et al.
2014-11-06
Coated lipid complexes and their use
Grant 8,852,472 - Keil , et al. October 7, 2
2014-10-07
Means for inhibiting the expression of ANG2
Grant 8,829,179 - Santel , et al. September 9, 2
2014-09-09
Means For Inhibiting The Expression Of Orc-1
App 20140249207 - GOSSEN; MANFRED ;   et al.
2014-09-04
Lipids, lipid complexes and use thereof
Grant 8,735,453 - Keil , et al. May 27, 2
2014-05-27
Means for inhibiting the expression of Orc-1
Grant 8,722,875 - Gossen , et al. May 13, 2
2014-05-13
Therapeutic uses of inhibitors of RTP801
Grant 8,642,571 - Feinstein , et al. February 4, 2
2014-02-04
Lipids, Lipid Complexes And Use Thereof
App 20130165381 - KEIL; OLIVER ;   et al.
2013-06-27
Interfering Rna Molecules
App 20130102769 - GIESE; KLAUS ;   et al.
2013-04-25
Therapeutic Uses Of Inhibitors Of Rtp801
App 20130095117 - Feinstein; Elena ;   et al.
2013-04-18
Lipids, lipid complexes and use thereof
Grant 8,357,722 - Keil , et al. January 22, 2
2013-01-22
Interfering RNA molecules
Grant 8,324,370 - Giese , et al. December 4, 2
2012-12-04
Therapeutic uses of inhibitors of RTP801
Grant 8,309,532 - Feinstein , et al. November 13, 2
2012-11-13
Means for inhibiting the expression of protein kinase 3
Grant 8,232,256 - Kaufmann , et al. July 31, 2
2012-07-31
Further Use Of Protein Kinase N Beta
App 20120171220 - KLIPPEL-GIESE; ANKE ;   et al.
2012-07-05
Methods of treating eye diseases in diabetic patients
Grant 8,168,607 - Feinstein , et al. May 1, 2
2012-05-01
Lipids, Lipid Complexes And Use Thereof
App 20120065138 - KEIL; OLIVER ;   et al.
2012-03-15
Means For Inhibiting The Expression Of Ang2
App 20120022138 - Santel; Ansgar ;   et al.
2012-01-26
Lipids, Lipid Complexes And Use Thereof
App 20110294871 - KEIL; OLIVER ;   et al.
2011-12-01
Lipids, lipid complexes and use thereof
Grant 8,017,804 - Keil , et al. September 13, 2
2011-09-13
Means For Inhibiting The Expression Of Orc-1
App 20110217367 - Gossen; Manfred ;   et al.
2011-09-08
Interfering RNA Molecules
App 20110118456 - Giese; Klaus ;   et al.
2011-05-19
Therapeutic uses of inhibitors of RTP801
App 20110117102 - Feinstein; Elena ;   et al.
2011-05-19
Interfering RNA molecules
Grant 7,893,245 - Giese , et al. February 22, 2
2011-02-22
Methods of treating eye diseases in diabetic patients
App 20110028532 - Feinstein; Elena ;   et al.
2011-02-03
Further Use of Protein Kinase N Beta
App 20110008320 - Klippel-Giese; Anke ;   et al.
2011-01-13
Therapeutic uses of inhibitors of RTP801
Grant 7,741,299 - Feinstein , et al. June 22, 2
2010-06-22
Further use of protein kinase N beta
Grant 7,713,943 - Klippel-Giese , et al. May 11, 2
2010-05-11
Coated Lipid Complexes And Their Use
App 20100062967 - Keil; Oliver ;   et al.
2010-03-11
Means for Inhibiting the Expression of Protein Kinase 3
App 20090304678 - Kaufmann; Jorg ;   et al.
2009-12-10
Means For Inhibiting The Expression Of Cd31
App 20090252783 - Kaufmann; Jorg ;   et al.
2009-10-08
Interfering Rna Molecules
App 20090186845 - GIESE; KLAUS ;   et al.
2009-07-23
Lipoplex Formulations For Specific Delivery To Vascular Endothelium
App 20090074852 - Kaufmann; Jorg ;   et al.
2009-03-19
Interfering RNA molecules
Grant 7,452,987 - Giese , et al. November 18, 2
2008-11-18
Lipids, Lipid Complexes and Use Thereof
App 20080274116 - Keil; Oliver ;   et al.
2008-11-06
Interfering RNA molecules
App 20040180351 - Giese, Klaus ;   et al.
2004-09-16
Further use of protein kinase N beta
App 20040106569 - Klippel-Giese, Anke ;   et al.
2004-06-03
Compounds and methods for the identification and/ or validation of a target
App 20030135033 - Klippel-Giese, Anke ;   et al.
2003-07-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed